Sunshine Biopharma Price Cash Flow Ratio Over Time
| SBFM Stock | USD 2.36 0.24 11.32% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sunshine Biopharma Performance and Sunshine Biopharma Correlation. Sunshine |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (127.90) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price Cash Flow Ratio Analysis
Compare Sunshine Biopharma and related stocks such as Shionogi, Alimera Sciences, and China SXT Pharmaceuticals Price Cash Flow Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SXTC | 565 | 565 | 565 | 565 | 565 | 565 | 565 | 565 | 565 | 14.8249 | (20.1126) | 21.7029 | (23.4387) | (0.7468) | (0.71) |
| SHPH | (20.6 K) | (20.6 K) | (20.6 K) | (20.6 K) | (20.6 K) | (20.6 K) | (20.6 K) | (20.6 K) | (7.4 K) | (155.9 K) | (155.9 K) | (13.9 K) | (59.8809) | (10.3743) | (10.89) |
| LFCR | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (789) | (389) |
| DERM | (1.9439) | (1.9439) | (1.9439) | (1.9439) | (1.9439) | (5.2415) | (4.2359) | (3.7065) | (1.8725) | 17.5501 | 30.8392 | (42.7152) | (2.4871) | 20.0417 | 21.04 |
| PTPI | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 0.4975 | 2.6895 | (2.7908) | (3.0571) | (0.3769) | (0.4023) | (0.42) |
| SNOA | (5.4863) | (9.0329) | 14.5848 | (5.3057) | (1.2117) | (1.7943) | (3.7082) | (1.3393) | (0.6529) | (1.5764) | (4.3903) | (2.5044) | (0.5387) | (0.58) | (0.61) |
| TKNO | 301 | 301 | 301 | 301 | 301 | 301 | 301 | 301 | 301 | 301 | 261 | (63.2579) | (5.7807) | (6.3085) | (5.99) |
| PAHC | (129) | 16.1869 | 1.2 K | (964) | 22.0868 | 19.7039 | 14.8727 | 26.4428 | 27.0904 | 17.9067 | 24.197 | 24.4823 | 41.6908 | 7.8794 | 7.49 |
Sunshine Biopharma and related stocks such as Shionogi, Alimera Sciences, and China SXT Pharmaceuticals Price Cash Flow Ratio description
My Equities
My Current Equities and Potential Positions
| Sunshine Biopharma | SBFM |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.36
Check out Sunshine Biopharma Performance and Sunshine Biopharma Correlation. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.